SCHEMBL9429122

SCHEMBL9429122

CC=CC(=O)N(c1ccc(OC)cc1)C1CCNC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.51
MC4R P32245 1/20 0.43
SLC6A2 P23975 6/20 0.43
SLC6A4 P31645 6/20 0.43
SLC6A3 Q01959 4/20 0.43
KCNH2 Q12809 4/20 0.43
CYP2D6 P10635 1/20 0.43
RPLP1 P05386 2/20 0.38
RPLP0 P05388 2/20 0.38
RPS17 P08708 2/20 0.38
RPSA P08865 2/20 0.38
RPS2 P15880 2/20 0.38
RPL35A P18077 2/20 0.38
RPL7 P18124 2/20 0.38
RPL17 P18621 2/20 0.38
RPS4Y1 P22090 2/20 0.38
RPS3 P23396 2/20 0.38
RPS12 P25398 2/20 0.38
RPL13 P26373 2/20 0.38
RPL10 P27635 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9429926 0.86 SLC6A4 (0.44) TRPM8MC4RSLC6A2SLC6A4SLC6A3
SCHEMBL9428924 0.86 SLC6A4 (0.44) TRPM8SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL9429947 0.85 SLC6A4 (0.46) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL9429217 0.83 SLC6A4 (0.47) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL9429644 0.82 APP (0.37) TRPM8MC4RALDH1A1SMN1; SMN2
SCHEMBL9428421 0.81 RAB9A (0.39) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL8377826 0.81 SLC6A3 (0.40) TRPM8SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL8379418 0.79 SLC6A4 (0.44) TRPM8SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL9428898 0.76 SLC6A4 (0.41) TRPM8SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL11301763 0.74 CA1 (0.51) TRPM8MC4RSLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5328907-A Treatment of allograft rejection in mammals and antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1994-07-12 US disclosed
US-5108999-A For treating inflammation, autoimmune disease or allograft rejection in mammals SYNTEX (U.S.A.) INC. (US) 1992-04-28 US disclosed
EP-0440503-A1 4-Isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-08-07 EP disclosed
US-5001124-A 4-isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-03-19 US disclosed